FTC Drops Bomb on Pom: Finds Ads Touting Health Benefits of Pomegranates Unsubstantiated and False

Last week, the Federal Trade Commission issued its much-anticipated ruling in the agency’s case against POM Wonderful. In a unanimous 5-0 decision, the Commission found that Pom’s advertisements touting the amazing health benefits of its pomegranate juice and supplements were false. Finding that Pom’s deceptive advertising was “serious and deliberate,” the Commission issued a 20-year injunction that bars Pom from making disease-treatment or prevention claims for any products, unless supported by “two randomized, well-controlled, human clinical trials.”

But the Commission stopped short of giving FTC prosecutors all of the relief they had requested. In a decision that should give some comfort to food and supplement makers, the Commission ruled that Pom is not required to obtain FDA’s prior approval before making health claims for its products in the future.

Please read full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  False Advertising, FDA, Food Labeling, Food Marketing, FTC, POM Wonderful

Published In: Antitrust & Trade Regulation Updates, Communications & Media Updates, Personal Injury Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patterson Belknap Webb & Tyler LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »